Structural

Case Presentation 2: Tricuspid Replacement with the Evoque Valve

10 min.

What Is the Future of Percutaneous Tricuspid Valve Procedures? Focus on ACHD

15 min.

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

15 min.

Extract or Go to Jail: CIED Lead Management in Patients Undergoing Tricuspid Valve Intervention

14 min.

Is That in My Way? The Interventional Cardiologist's Perspective

17 min.

Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial

14 min.

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

11 min.

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

6 min.

Case Resolution: Case of TTVI in Lead-induced: TR Assessment and Management

4 min.

TTVI in Lead Induced TR: Assessment and Management

12 min.

Case Presentation: TTVI in the Failing Right Heart

3 min.

Case Resolution: TTVI in the Failing Right Heart

9 min.

Case Presentation: TTVI in Patients with Large Gaps

3 min.

TTVI in Patients with Large Gaps/Tethering

5 min.

Case Resolution: TTVI in Patients with Large Gaps

4 min.

Case Presentation: Case of TTVI in Lead-induced: TR Assessment and Management

2 min.

Transcatheter Tricuspid Valve Replacement - TRISCEND II

7 min.

Assessing Functional Status and Predicting Clinical Improvement

7 min.

Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement

7 min.

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

14 min.

Case-in-Box - Cardiovalve

15 min.

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

16 min.

Live Case: LUX Tricuspid Valve Replacement – St. Michael's Hospital, Toronto, Canada

30 min.

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

12 min.

Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging

17 min.

Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry

16 min.

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

15 min.

TRISCEND II: Understanding the Study Design and Interpreting the Results

8 min.

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

5 min.

Lead Management Considerations in TR Patients

6 min.

A Concise Overview of Right Heart Physiology and Relevance to TR Management

10 min.

EVOQUE System and the TMTT Portfolio

20 min.

Case Resolution: A Non-Surgical Patient With Complex Tricuspid Valve Disease

8 min.

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

15 min.

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

7 min.

Case Presentation: A Non-Surgical Patient With Complex Tricuspid Valve Disease

4 min.

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

13 min.

Pre-Existing and New CIED: The Achilles Heel of Transcatheter Tricuspid Valve Replacement?

15 min.

Patient Selection in Transcatheter Tricuspid Valve Replacement: How to Best Use Multimodality Imaging?

15 min.

What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly

13 min.

Case Resolution: Severe Tricuspid Regurgitation in Right Heart Failure and Severe Tricuspid Regurgitation

6 min.

Case Discussion: Severe Tricuspid Regurgitation in Right Heart Failure and Severe Tricuspid Regurgitation

21 min.

Next Generation TTVR: Overview of Devices and Current Status

9 min.

Orthotopic TTVR: What Have We Learned From the EFS studies

14 min.

Why TTVR Over TEER: Anatomic and Clinical Considerations

10 min.

Heterotopic TTVR: Clinical Updates and Device Overviews

10 min.

Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?

6 min.

Who Are the TTVR Patients We Are Treating and What Are the Challenges?

9 min.

Keynote Lecture: Patient Selection for Transcatheter Tricuspid Valve Interventions: Imaging and Clinical Drivers

18 min.

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

22 min.

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

7 min.

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

9 min.

TMVR vs Transcatheter Edge-to-Edge Repair: Lessons From Europe

7 min.

No, It's never too late for TTVI !

16 min.

Yes, It can be already too late for TTVI !

5 min.

Transjugular Tricuspid Valve Replacement Using the LUX Valve in Western China

12 min.

Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors

9 min.

A Comprehensive Overview of New Transcatheter TR Therapies

8 min.

Current Clinical Evidence Following TR Interventions

20 min.

Tricuspid Valve Interventions: When Is the RV Too Sick?

8 min.

When Heterotopic TTVR is the Optimal Choice: A Series of Complex Case Examples

7 min.

Heterotopic TTVR Indications Are Limited, and Should Be Considered Palliative Therapy

9 min.

KEYNOTE LECTURE: The Concept of Heterotopic TTVR: Pathophysiologic and Anatomical Considerations; TRICUS and TRICAV Clinical Trial Updates

22 min.

Case Presentation: A Patient With Severe TR and Limited Therapeutic Options

4 min.

Leaflet Modification and Septal Reduction in Bioprosthetic Mitral Intervention (When and Why)

17 min.

Emerging TTVR Solutions and Remaining Unmet Clinical Needs

26 min.

Are TMVR Devices Designed to Meet the Tricuspid Needs? – Technological Challenges and Opportunities for Innovation

8 min.

TTVR Will Rapidly Become the Gold Standard of TR Treatment

8 min.

SPOTLIGHT LECTURE: Defining the Ideal Candidate for Orthotopic TTVR - Clinical and Anatomical Considerations

17 min.

Clinical Data (and Experience) in TTVR: The Good, the Bad, and the Ugly

14 min.

TTVR Use Will Be Reduced to a Specific Patient and Anatomical Subset!

12 min.

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

13 min.

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

22 min.

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

7 min.

The VDyne TTVR System: Early Human Clinical Results

17 min.

SPOTLIGHT INNOVATION LECTURE: Making the Case for TTVR and the Need for the Development of Dedicated Replacement Systems

19 min.

Early Human Experience With the Venus MedTech Cardiovalve TTVR System

6 min.

First-in-Human Transfemoral Tricuspid Valve Replacement With an Innovative Transcatheter Heart Valve Replacement System (TriCares TOPAZ)

5 min.

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

5 min.

Thrombosis, HALT, and Bleeding Risk

5 min.

Predictors of TTVR Success and Failure: Imaging and Technical Considerations

7 min.

Right-Ventricular Failure

5 min.

PPM Lead Dislodgement and New PPM Requirements

6 min.

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

8 min.

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

3 min.

TCT 694: Debulking Tricuspid Valve Vegetations: Using AngioVac to Avoid Reoperations for Prosthetic Valve Endocarditis

6 min.

TCT 815: Percutaneous Mechanical Tricuspid Valve Paravalvular Leak Closure: Important Technical Considerations

5 min.

TCT 689: Transfemoral transcathetertricuspid valve replacement in a patient with moderate right ventricular dysfunction

6 min.

TCT 620: Valve-in-valve transcatheter tricuspid valve replacement in the patient with pacemaker-dependent complete heart block

5 min.

TCT 639: Technically Challenging Transcatheter Tricuspid Valve in Valve Procedure for Right Heart Failure

5 min.

Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences

6 min.

From Bench to Preclinical: Key Tests and Considerations

5 min.